Exhibit 16.1
March 13, 2018
Securities and Exchange Commission
100 F Street N.E.
Washington, DC 20549
We have read Item 4.01 of Form 8-K dated March 13, 2018, of AxoGen, Inc. and are in agreement with the statements made in response to that Item insofar as they related to our Firm.
Very truly yours,
/s/Lurie, LLP
Lurie, LLP
2501 Wayzata Boulevard • Minneapolis, MN 55405 • O/612.377.4404 • F/612.377.1325 • LurieLLP.com